Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
Peramiquel
Laura
L
Dalmau
Joan
J
Puig
Luís
L
Roé
Esther
E
Fernández-Figueras
M Teresa
MT
Alomar
Agustín
A
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004890:Erythema / Q000139:chemically induced; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007642:Keratosis / Q000139:chemically induced*; D008297:Male; D010292:Paresthesia / Q000139:chemically induced*
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil